Bibliografía del artículo
1. Bocchi EA, Marcondes-Braga FG, Ayub-Ferreira SM, e col. Sociedade Brasileira de Cardiologia. III Diretriz Brasileira de Insuficiência Cardíaca Crônica. Arq Bras Cardiol 93(1 supl. 1):1-71, 2009.
2. Bocchi EA, Guimarães G, Tarasoutshi F, Spina G, Mangini S, Bacal F. Cardiomyopathy, adult valve disease and heart failure in South America. Heart 95(3):181-9, 2009.
3. Biomarkers Definitions Working Group.. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89-95, 2001.
4. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kübler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 21(12):1349-53, 1989.
5. Kushner FG, Hand M, Smith SC Jr, e col. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54(23):2205-41, 2009.
6. Wallace TW, Abdullah SM, Drazner MH, e col. Prevalence and determinants of troponin T elevation in the general population. Circulation 113(16):1958-65, 2006.
7. Missov E, Calzolari C. Elevated cardiac troponin I in some patients with severe congestive heart failure [abstract]. J Mol Cell Cardiol 27:A-405, 1995.
8. Missov E, Calzolari, Pau B. High circulating levels of cardiac troponin I in human congestive heart failure [abstract]. J Am Coll Cardiol 27(Suppl A):338A, 1996.
9. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96(9):2953-8, 1997.
10. Kociol RD, Pang OS, Gheorgiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in in heart failure. J Am Coll Cardiol 56(14):1071-8, 2010.
11. Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz CM, Latorre MRDO, Ramire JAF. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Card Fail 10(1):43-8, 2004.
12. Del Carlo CH, O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J 138(4 Pt 1):646-53, 1999.
13. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 341(8):577-85, 1999.
14. Ricchiuti V, Zhang J, Apple FS. Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 43(6 Pt 1):990-5, 1997.
15. Narula J, Haider N, Virmani R, e col. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335(16):1182-9, 1996.
16. Olivetti G, Abbi R, Quaini F, e col. Apoptosis in the failing human heart. N Engl J Med 336(16):1131-41, 1997.
17. Narula J, Haider N, Arbustini E, Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure--seeing hope in death. Nat Clin Pract Cardiovasc Med 3(12):681-8, 1996.
18. Colucci WS. Apoptosis in the heart. N Engl J Med 335(16):1224-6, 1996.
19. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161(7):996-1002, 2001.
20. Uretsky BF, Thygesen K, Armstrong PW, e col. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 102(6):611-6, 2000.
21. Fang ZY, Marwick TH. Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Am Heart J 143(3):383-90, 2002.
22. Conway RS, Natelson BH, Chen WH, Ting W. Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis. Cardiovasc Res 28(3):320-4, 1994.
23. Liu PP, Mak S, Stewart DJ. Potential role of the microvasculature in progression of heart failure. Am J Cardiol 19;84(4A):23L-26L, 1999.
24. Roura S, Bayes-Genis A. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 6(9):590-8, 2009.
25. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, e col. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 35(1):19-28, 2000.
26. Vogt M, Strauer BE. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 76(13):48D-53D, 1995.
27. Logeart D, Beyne P, Cusson C, e col. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 141(2):247-53, 2001.
28. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103(16):2035-7, 2001.
29. Saravia SG, Haberland A, Bartel S, e col. Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch Pathol Lab Med 135(2):243-8, 2011.
30. Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz CM, Latorre Mdo R, Oliveira Junior MT, Ramires JA. Cardiac troponin T for risk stratification in decompensated chronic heart failure. Arq Bras Cardiol 92(5):372-80, 2009.
31. Oliveira MD, Alvares J, Moreira MC. Single cardiac troponin T measurement predicts risk for adverse outcome in decompensated heart failure. Arq Bras Cardiol 94(4):527-34, 2010.
32. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 115(9):1109-23, 2007.
33. Higuchi ML, Fukasawa S, De Brito T, Parzianello LC, Bellotti G, Ramires JA. Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 82(3):279-85, 1999.
34. La Vecchia L, Mezzena G, Ometto R, e col. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 80(1):88-90, 1997.
35. Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH; ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358(20):2117-26, 2008.
36. You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153(4):462-70, 2007.
37. Latini R, Masson S, Anand IS, e col.; Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116(11):1242-9, 2007.
38. Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 54(18):1715-21, 2009.
39. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89(6):691-5, 2002.
40. Thygesen K, Alpert JS, White HD et al, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Universal definition of myocardial infarction. Circulation 116(22):2634-53, 2007.